These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 8944605

  • 1. Inappropriate phosphate excretion in idiopathic hypercalciuria: the key to a common cause and future treatment?
    Williams CP, Child DF, Hudson PR, Soysa LD, Davies GK, Davies MG, De Bolla AR.
    J Clin Pathol; 1996 Nov; 49(11):881-8. PubMed ID: 8944605
    [Abstract] [Full Text] [Related]

  • 2. The effect of an oral sodium phosphate load on parathyroid hormone and fibroblast growth factor 23 secretion in normo- and hypercalciuric stone-forming patients.
    Irzyniec T, Boryń M, Kasztalska J, Nowak-Kapusta Z, Maciejewska-Paszek I, Grochowska-Niedworok E.
    Clin Nutr; 2020 Dec; 39(12):3804-3812. PubMed ID: 32386861
    [Abstract] [Full Text] [Related]

  • 3. Renal phosphate leak in patients with idiopathic hypercalciuria and calcium nephrolithiasis.
    Negri AL, Spivacow R, Del Valle E, Fradinger E, Marino A, Zanchetta JR.
    Urol Res; 2003 Dec; 31(6):378-81. PubMed ID: 13680023
    [Abstract] [Full Text] [Related]

  • 4. [Renal tubular function in children with hypercalciuria].
    Kovacević L, Kovacević S, Smoljanić Z, Kostić M, Peco-Antić A, Gajić M, Kovacević M, Jovanović O.
    Srp Arh Celok Lek; 1998 Dec; 126(7-8):223-7. PubMed ID: 9863386
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Distinct phenotype of kidney stone formers with renal phosphate leak.
    Dhayat NA, Lüthi D, Schneider L, Mattmann C, Vogt B, Fuster DG.
    Nephrol Dial Transplant; 2019 Jan 01; 34(1):129-137. PubMed ID: 29939320
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Renal threshold phosphate concentration in patients with idiopathic nephrolithiasis: correlations with tubular functions, serum parathyroid hormone and 1,25(OH)2D3.
    Pabico RC, McKenna BA, Freeman RB.
    Proc Eur Dial Transplant Assoc; 1983 Jan 01; 20():450-4. PubMed ID: 6689210
    [Abstract] [Full Text] [Related]

  • 10. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria.
    Pak CY, Oata M, Lawrence EC, Snyder W.
    J Clin Invest; 1974 Aug 01; 54(2):387-400. PubMed ID: 4367891
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Frequency of renal phosphate leak among patients with calcium nephrolithiasis.
    Prié D, Ravery V, Boccon-Gibod L, Friedlander G.
    Kidney Int; 2001 Jul 01; 60(1):272-6. PubMed ID: 11422761
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 01; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 17. Renal clearance of phosphate and calcium in vitamin D-deficient chicks: effect of calcium loading, parathyroidectomy, and parathyroid hormone administration.
    Clark NB.
    J Exp Zool; 1991 Aug 01; 259(2):188-95. PubMed ID: 1664453
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Has vitamin D a direct renal effect on the tubular reabsorption of phosphate? A study in parathyroidectomized (PTX) and non-PTX man.
    Madsen S, Olgaard K.
    Adv Exp Med Biol; 1978 Aug 01; 103():111-23. PubMed ID: 717102
    [Abstract] [Full Text] [Related]

  • 20. An assessment of parathyroid hormone, calcitonin, 1,25 (OH)2 vitamin D3, estradiol and testosterone in men with active calcium stone disease and evaluation of its biochemical risk factors.
    Shakhssalim N, Gilani KR, Parvin M, Torbati PM, Kashi AH, Azadvari M, Golestan B, Basiri A.
    Urol Res; 2011 Feb 01; 39(1):1-7. PubMed ID: 20490785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.